After double-strand break induction, formation of γ-H2AX foci due to phosphorylation at Ser-139 of histone H2AX represents an early event of the DNA damage response (DDR). γ-H2AX foci are then rapidly dephosphorylated as signal for the subsequent recruitment of effector proteins. The induction and disappearance of the foci can be, therefore, used to monitor the functioning of the DDR machinery in a cell population exposed to genotoxic stress. Here, we investigated the time-course of γ-H2AX in unstimulated or cultured peripheral lymphocytes in vitro treated with UVB, bleomycin and mitomycin C (MMC). Once the mutagen exposure was performed, cells were harvested at different interval times from 0.5 to 5 h. The results show that (i) in 20-h stimulated peripheral lymphocytes, UVB irradiation caused extensive and dose-dependent increases in nuclear phosphorylation, and disappearance of γ-H2AX foci progressed, proportionally to the UV fluence, with increasing the harvesting time; (ii) UVB-exposed G 0 cells cultured for 20-h post-irradiation displayed low amounts of DNA phosphorylation, depicting a time-course in which the maximum effect was reached at 0.5 h and dephosphorylation started after 1 h; (iii) treatment of unstimulated lymphocytes with bleomycin sulphate induced an increase in nuclear phosphorylation of several folds higher than that of untreated cells, depicting kinetics comparable to those observed for UVB-exposed G 1 cells; (iv) in stimulated cells, MMC caused a severe and dose-dependent high degree of H2AX phosphorylation together with a very slower kinetic of dephosphorylation with respect to the other experimental treatments. This study confirms the feasibility of the γ-H2AX focus assay as a genotoxic end-point and supports the view that the proposed type of analysis should be introduced in biomonitoring studies of human populations. This could also represent a feasible and useful tool in the screening and diagnosis of precancerous states or very early stages of other diseases.
Introduction
The presence of DNA double-strand breaks (DSB) in a somatic cell has the immediate consequence of impairing DNA replication, transcription or distribution of the genetic material to daughter cells. Maintenance of genome integrity is, therefore, essential for human cells, as this lesion can in turn cause cell death if unrepaired, chromosome mutations if miss repaired and ultimately cancer. However, following DSB induction, mammalian cells elicit a DNA damage response (DDR) that results, before either homologous recombination or nonhomologous end-joining repair systems (or both) are triggered, in rapid phosphorylation at Ser-139 of histone H2AX by the serine/threonine protein kinases Ataxia telangiectasia mutated, Ataxia telangiectasia and Rad3 related or DNA-dependent protein kinase. About 2000 histone H2AX molecules around the site of each DSB are phosphorylated to originate the so-called γ-H2AX foci (1) (2) (3) (4) (5) (6) . Hence, it has been assumed that the number of γ-H2AX foci reflects approximately the number of nuclear DSB formed, thus making γ-H2AX an excellent marker of early DNA damage. Several scientific reports deal with the application of the γ-H2AX focus assay, initially developed and validated in radiation biology studies, to investigate the action of genotoxic/ carcinogenic agents (7) or the processes by which normal cells age or become cancer cells (8) (9) (10) (11) , and to associate the presence of DSB to environmental or diagnostic exposures and pathological conditions (12) (13) (14) (15) (16) . γ-H2AX formation is rapidly followed by its dephosphorylation as signal for the subsequent recruitment of effector proteins. The induction and disappearance of this marker can be, therefore, used in base research studies to monitor the functioning of the DDR machinery in a given cell population, assuming that its coordinated occurrence is required to avoid the fixation of DSB into chromosome mutations (17, 18) . With this background in mind and considering that humans continuously receive genotoxic stresses from the environment, we aimed to investigate the time-course of γ-H2AX foci (i.e. their occurrence, persistence and reduction or complete disappearance) in peripheral lymphocytes in vitro treated with the UVB component of solar light or the anticancer drugs bleomycin and mitomycin C (MMC) as physical or chemical mutagens, respectively.
Materials and methods

Cell cultures, mutagen treatment and cell harvesting
Heparinised whole blood samples were obtained by venipuncture from three healthy 23-to 26-year-old, non-smoking and properly informed male donors. The study was performed according to the ethical committee of Pisa University. Depending on the nature of the agent used, we treated in vitro either unstimulated or stimulated T-lymphocytes with physical (UVB light) or chemical (bleomycin and MMC) mutagens. Two experiments, consisting of a series of at least two independent cultures per experimental point, were performed for each mutagen treatment. Culture tubes, containing 300 µl of whole blood and 4.7 ml of RPMI-1640 medium (Invitrogen, Milano, Italy) supplemented with 20% foetal bovine serum (Invitrogen), 1% antibiotic/ antimycotic (Invitrogen) and 1.5% phytohaemagglutinin (PHA; Invitrogen), were divided into two tubes of 2.5 ml each before treatment. For experiments with unstimulated lymphocytes, the cell samples were immediately treated with the mutagens, whereas cultures designed to be treated after PHA stimulation were pre-incubated at 37°C for 20 h. The UV-light-generating lamp consists of fluorescent narrowband tubes emitting in the 315-280 nm range (UVB TL 20W/01 RS SLV; Philips, Milano, Italy). Both unstimulated and 20-h stimulated lymphocytes were then exposed to the UV light in Petri dishes and placed at 30 cm from the UV source. UVB irradiation was performed at 5.26 W/ , as measured by a radiometric-calibrated detection system consisting of an InstaSspec IV CCD detector head coupled to an MS125 spectrograph (Oriel Instruments, Milano, Italy). Cells were then exposed (varying the exposure time) to 0.6, 2.4 and 4.8 kJ/m 2 of UVB. In the case of negative controls (UV-light dose = 0.0 kJ/m 2 ), cells remained under the turned-off UV lamp for the time used to obtain the maximum dose. After exposure, stimulated cells were immediately transferred to culture tubes at 37°C and harvested after 0.5, 1, 2, 3 and 5 h, whereas unstimulated cells were cultured for 20 h in complete medium at 37°C before they were harvested as above described.
Chemical treatment was performed with the radiomimetic drug bleomycin sulphate (BLM; 15 000 U.I from Nippon Kayaku, Sanofi-aventis, Milano, Italy) on unstimulated cells and with the bifunctional alkylating agent MMC (Sigma-Aldrich, Milano, Italy) on stimulated cells, at the following final concentrations: BLM, 1.75, 3.50 and 7.0 µM; MMC, 0.3, 1, 3 and 6 µM. Chemical mutagens were dissolved in sterile H 2 O, and the corresponding negative control cultures received only the solvent used. Treated or untreated cells were then transferred to culture tubes at room temperature and harvested after 1, 2, 3 and 4 h. Cell harvesting was carried out according to the procedure described elsewhere (19) . Briefly, after hypotonic treatment with 0.075 M KCl, lymphocytes were pre-fixed in acetic acid:methanol 5:3, fixed in 100% methanol, washed twice in methanol:acetic acid (3:1) and then dropped onto clean glass slides. The air-dried slides were immediately processed by the immunofluorescence protocol for visualisation of γ-H2AX nuclear foci.
γ-H2AX immunofluorescence assay
Slides were processed according to manufacturing instructions using phosphohistone H2AX (Ser-139) monoclonal antibody (Cell Signaling, Milano, Italy), DyLight 488-conjugated anti-rabbit antibody as secondary antibody (Pierce, Milano, Italy) and 4',6-diamidino-2-phenylindole (DAPI) at 0.4 µg/ml in antifade solution (Fluorguard, LiStarFish, Milano, Italy) as counterstaining. Briefly, cells were washed twice in 1× phosphate-buffered saline (PBS), blocked in 1× PBS/0.3% Triton X-100 (PBS/Triton; Sigma-Aldrich), washed again three times in 1× PBS and incubated overnight at 4°C with primary antibody diluted 1:50 PBS/Triton. The following day, cells were washed three times in 1× PBS and then incubated at room temperature for 2 h with secondary antibody diluted 1:250 in PBS/Triton. After three washes in 1× PBS, slides were counterstained with 10 µl of DAPI in antifade solution (Fluorguard) Slide scoring and statistical evaluation Slides were analysed on a Nikon-Optiphot-2 fluorescence microscope properly equipped with two filters specific for DAPI and fluorescein isothiocyanate visualisation. Using a ×100 lens (×1000 final magnification), mononuclear cell nuclei appeared blue coloured through the DAPI filter, and the presence of γ-H2AX foci was easily detected as green fluorescence spots within the localised nuclei. At least 400 cells per culture were scored by four skilful cytogenetists who assured a careful and blind counting. The extent of DNA damage was expressed as average number of γ-H2AX foci per nucleus (γ-H2AX F/N) or mean percentage of γ-H2AX-positive nuclei (γ-H2AX+N). A positive nucleus is a nucleus showing at least one clear visible fluorescent spot (see Figure 1) .
As we performed a manual scoring of the foci, when highly damaged nuclei did not allow a precise count of the number of foci (generally until 50 foci per nucleus), we arbitrarily assigned them the value of 60. However, it should be underlined that we observed a small fraction of these cells and only after 3 or 6 µM MMC. Statistical calculations were performed with the STATGRAPHICS Plus version 5.1 (Statistical Graphics Corporation, 2001, Rockville, MD, USA) software package. When analysed, data were reported as mean ± standard error (SE). The effect of mutagen treatments on γ-H2AX foci was evaluated using Dunnett's test, which allows a multiple comparison between treated versus control cultures, either among doses at each harvesting times or among harvesting times at each dose.
Results
UVB exposure
The time-course of Ser-139 histone phosphorylation (expressed as average value of foci per nucleus and percent of γ-H2AX-positive nuclei) after UVB exposure of unstimulated or stimulated peripheral blood lymphocytes is shown in Figures  2 ), for all the tested doses. From 1 h on, the levels of dephosphorylation increased with the increasing of time elapsed from UVB exposure until, at the lowest dose (0.6 kJ/m 2 ), the number of γ-H2AX foci at 5 h did not differ from that of control (0.00125 ± 0.00032). At the 3-h harvesting time, the average values of both nuclear damage parameters for cells exposed to 2.4 and 4.8 kJ/m 2 lowered clearly even though they remained significantly higher than those of untreated lymphocytes, and only after 5 h, they were comparable to that of untreated lymphocytes. The pattern of nuclear phosphorylation following UVB exposure of 20-h-stimulated T-lymphocytes is graphically visualised in Figure 3 . At 0.6 kJ/m 2 , we observed significantly higher values (P < 0.001; 0.488 ± 0.10 γ-H2AX F/N and 8.75 ± 1.75% γ-H2AX+N) than that of control cultures (0.0075 ± 0.0045 γ-H2AX F/N and 0.25 ± 0.13% γ-H2AX+N) already 0.5 h after the treatment. After 1 h, the presence of nuclear foci dramatically decreased (0.015 ± 0.0078 γ-H2AX F/N and 1.0 ± 0.19% γ-H2AX+N) and was maintained at the same levels after 2 h, and then the levels fell to the control values 3 h after the treatment. At 2.4 kJ/m 2 of UVB, the frequencies of γ-H2AX foci after 0.5 h did not differ from those of controls, whereas these values increased significantly 1 h after the exposure, reaching the peak (1.145 ± 0.045 γ-H2AX F/N and 16.25 ± 2.05% γ-H2AX+N). Thereafter (2, 3 and 5 h after the exposure), the means of foci per nucleus and percentage of γ-H2AX-positive nuclei began to decline significantly with respect to the previous values, even though they remained still significantly higher than the respective controls until 3 h. At 4.8 kJ/m 2 , H2AX phosphorylation began to differ significantly, although moderately, from untreated lymphocytes already 0.5 h after the exposure, but the frequencies increased drastically 1 h post-irradiation (1.222 ± 0.080 γ-H2AX F/N and 20.75 ± 1.35% γ-H2AX+N) reaching the maximum values at 2 h (1.288 ± 0.051 γ-H2AX F/N and 24.0 ± 2.25% γ-H2AX+N). At 3-and 5-h harvesting time, nuclear phosphorylation decreased significantly as compared with the previous values, whereas they remained higher (0.14 ± 0.09 γ-H2AX F/N and 2.75 ± 1.19% γ-H2AX+N at 5 h) than the corresponding untreated cultures. Interestingly, computing, at each UVB dose, the excess of the number of foci per nucleus after normalising for the UVB dose (at the harvesting time where the maximum effect was observed), both non-cycling and cycling cells showed a comparable trend. .50 ± 7.6%). Once again, disappearance of γ-H2AX foci began 3 h after the cells were treated with MMC, but the time-course of nuclear phosphorylation progressed in a clearly dose-dependent manner between the two parameters. Cells exposed to 0.3 µM MMC reduced quite drastically the number of γ-H2AX foci per nucleus to 0.435 ± 0.16 (about 20-fold), whereas the fraction of positive nuclei decreased to a minor extent (about 5-fold) to 6.0 ± 2.7%. Treatment with 1 µM caused a moderate (3.5-fold) and a low (1.2-fold) reduction for γ-H2AX F/N (7.31 ± 0.12) and γ-H2AX+N (60.0 ± 3.3%), respectively. The two highest doses determined only a very little decrease in nuclear phosphorylation, the extent of which was comparable for both parameters (43.4 ± 0.31 and 89.5 ± 6.12% or 47.63 ± 0.45 and 95.0 ± 4.89 for 3 or 6 µM, respectively). After 4 h, the level of nuclear damage was still high at all the tested doses, with the exception of MMC 0.3 µM. In fact, at 1, 3 and 6 µM, we continued to detect 48.0 ± 3.5%, 61.0 ± 6.4% and 62.0 ± 3.6% of γ-H2AX-positive nuclei, respectively, or 5.02 ± 0.27, 10.68 ± 0.31 and 21.79 ± 0.45 of γ-H2AX F/N, respectively. When we applied the same calculation performed in the case of UVB exposure, the excess of the number of foci per nucleus per unit dose of the two chemicals followed approximately the previously observed trend. The corresponding values for BLM or MMC were 0.17 (1.75 µM), 0.111 (3.75 µM) and 0.077 (7.0 µM) or 27.14 (0.3 µM), 26.07 (1 µM), 14.94 (3 µM) and 8.24 (6 µM), respectively.
Discussion
Both the two parameters used for measuring the extent of DNA damage and describing the time-course of nuclear phosphorylation displayed a comparable sensitivity, even though, in general, the number of foci was more precise than the proportion of positive nuclei.
The presence of γ-H2AX foci in treated peripheral lymphocytes is the consequence of the induction of nuclear lesions that promptly activates DDR, whereas the disappearance of the foci is caused by the progression of the DDR itself. However, the two sequential events cannot occur always concurrently for all the cells, as the initial lymphocyte population is not synchronised in each culture. For example, the majority of T-cells, 20 h after PHA stimulation, are in the S-phase of the cycle, but a significant fraction of them can be still in G 1 , or already progressed to G 2 . Hence, it is likely that H2AX phosphorylation and dephosphorylation may take place at each harvesting time with a different kinetic for the various cell groups. It should also be remembered that the two modalities used to perform mutagen treatment were substantially different each other. During UV-light exposure, the cells were no more in contact with the mutagen after the end of irradiation, whereas in the case of chemical treatment, we appositely chose to unremove the drugs until harvesting. In addition, it has been demonstrated that disappearance of ionising radiation-induced γ-H2AX foci can occur not only via dephosphorylation but also through the complete replacement of a significant fraction of them with unphosphorylated H2AX molecules (20) . All these conditions, therefore, contributed to determine the net count of the foci in the cultures.
With regard to UV light, a transition through S-phase is required to transform UVB-induced DNA damage into DSB giving rise to H2AX phosphorylation (21) . DSB are, in fact, generated as the consequence of a stalling of the replication forks at the sites of the primary unrepaired DNA lesions that would force an activated endonuclease to cleave the DNA in the opposite strand (22, 23) . In this study, when peripheral lymphocytes were irradiated 20 h after PHA stimulation, we observed extensive, and dose-dependent, increases in nuclear phosphorylation; in addition, disappearance of γ-H2AX foci progressed, proportionally to the UV fluence, with increasing the harvesting time. In these cells, in fact, due to a different amount of DSB, H2AX dephosphorylation started 1-or 2-h post-irradiation at the lowest or the two highest doses tested, respectively. UVB-exposed G 0 cells cultured for 20-h post-irradiation displayed a very low amount of DNA phosphorylation even though they depicted a timecourse in which the maximum effect was reached at 0.5 h and dephosphorylation started after 1 h. Our results agree with the finding that, at comparable UVB doses, the levels of γ-H2AX foci induced in two different human cell lines (HeLa or HL-60) were much higher when cells were exposed in S-phase rather than in G 1 (24) . In addition, human keratinocytes exposed to 4 kJ/m 2 UVB released several pro-inflammatory cytokines and tumour necrosis factor-α that can lead to cell death via DSB formation (25) . This was also corroborated by a recent study in which low-intensity UVB exposures (50 J/m 2 ) led to induction of DSB in S-phase-irradiated human lung carcinoma A549 cells with peak of γ-H2AX foci at 2-h post-irradiation and completion of H2AX dephosphorylation after 4 h (26). In this study, probably due to difference in the dosage we used, UVBirradiated peripheral lymphocytes showed, at the highest dose, γ-H2AX levels still higher (even though consistently reduced) than untreated cells, 5-h post-irradiation. In fact, nuclear phosphorylation was observed to decline more slowly or faster for those cells that were exposed to the highest or lowest doses, respectively. Interestingly, some authors have recently shown, using another marker of nuclear damage (53bp1), that in human mammary epithelial cells, the kinetic of repair after exposure to ionising radiation is dose dependent and slower at higher dose (27) , and the data here reported are consistent with this finding. Thus, the higher the UVB dose, the higher the time that damaged cells required to initiate and prosecute DDR, if exposed in S-phase. This may depend on the fact that activation of the DDR in S-phase-exposed cells is delayed as the consequence of a major production of DNA lesions. In the case of G 0 exposure, despite the fact that the lymphocytes were allowed to transit through an S-phase, the entity of H2AX phosphorylation was low, very likely because the cells have had the time to repair the major part of the UVB-induced lesions. However, indirect formation of DSB can also be observed as the consequence of an increased oxidative endogenous metabolism after PHA stimulation and cycling (28, 29) . At least at these doses, the phase of the cell cycle in which the cells are exposed (e.g. G 0 or G 1 /S) is quite relevant for determining the extent of the nuclear damage (DSB) induced by UVB that, indeed, seems to be better counteracted by lymphocytes early exposed (in G 0 ), and then cycling, than by cycling cells exposed directly. This may be the consequence of the production of antioxidant and/or repair proteins. PHA stimulation and the subsequent 20-h culturing would render the G 0 -exposed lymphocytes able to quicken the repair processes of the radio-induced damage, as some of the involved enzymes or proteins are already present within the cells and they can be recruited faster.
The pattern of nuclear damage and phosphorylation induced by chemical treatment was very different due to the mode of action of the drugs, the phase of the cell cycle in which lymphocytes were treated, or because of both. In fact, treatment of unstimulated lymphocytes with BLM induced high levels of nuclear phosphorylation (about 40-folds the control value at the maximum dose tested) depicting a kinetic comparable to that observed for UVB-exposed G 1 cells, although with a timing shifted of 1 h. BLM is a radiomimetic DSB-inducing drug currently used in combination therapy for the treatment of certain human cancers (30, 31) . BLM, which is not active per se but requires metabolic activation, forms a ternary complex with Fe ++ and O 2 that originates highly reactive species capable of abstracting hydrogen from the DNA sugars and then damage DNA to give both single-strand breaks and DSB (32, 33) . Our data confirm previous findings indicating that (i) no further period of culturing was required for induction of the damage in unstimulated lymphocytes (15) , (ii) mouse or human cells treated with the drug displayed relevant increase in nuclear phosphorylation following DSB induction (7, 34, 35) , (iii) exposure to BLM produced γ-H2AX foci also in non-Sphase human cells already 1 h after the treatment, with at least a 2-fold reduction in their number within 3.5 h (36) . The pattern of dephosphorylation in unstimulated lymphocytes after BLM exposure progressed, as already mentioned, according to the same kinetic observed when 20-h cultured cells were exposed to UV light, as 4-or 5-h post-treatment, respectively, the damage was still present. This occurs, in fact, as cycling cells are able to trigger the repair processes of DNA damage faster than G 0 cells.
A different and more complex time-course of nuclear phosphorylation was observed in the case of treatment with the anticancer drug MMC, probably also as a partial consequence of the complexity of the bioactivation pathways undergone by MMC. MMC, in fact, is a potent antitumor antibiotic acting as a bifunctional alkylating agent that leads to intrastrand and interstrand DNA crosslinks, the most toxic complexes generating DSB (37, 38) . Treatment of stimulated cells with MMC caused, in fact, a severe and dose-dependent DNA damage, which resulted in a high degree of H2AX phosphorylation (almost the entire cell population score showed a diffuse presence of foci at the highest doses). This was also confirmed by observation of a much slower kinetic of dephosphorylation with respect to the other experimental treatments: even though the number of foci per nucleus was generally decreased and the percentage of damage nuclei remained always quite elevated also 4 h after the treatment at 10, 30 and 60 µM. In this case, it should not be ruled out that cells (especially later harvested) could also undergo toxic effects by the drug in response to a continuous mutagenic stimulus, thus delaying activation of the DDR in some cells. This may occur following impairment of physiological cellular functions such as synthesis or transport of DDR proteins toward the sites of nuclear damage, with the consequence that the induced γ-H2AX foci would tend to persist. In this view, a slowed mobilisation of repair proteins, probably due to their decreased expression, was detected during cell senescence or in ionising-radiation-treated cells from aging donors (39) (40) (41) . It is likely that the persistence of nuclear phosphorylation could also depend on the presence of a high number of DNA sites containing unrepairable DSB (42) . However, it should also be remembered that nuclear phosphorylation can be induced during apoptosis in response to extensive DNA fragmentation (43) . The small percentages of cells treated with 3 and 6 µM MMC that showed a multitude of spots might just reflect this situation.
Conclusions
This work, describing the time-course of H2AX phosphorylation in whole blood cultures of peripheral human lymphocytes treated with single physical or chemical mutagens, confirms the feasibility of the γ-H2AX focus assay as valid genotoxic end-point. Considering that the interval time we investigated was limited to no more than 5 h after the treatment or completion of a transition into an S-phase, the kinetic of γ-H2AX foci was seen to be dependent, at least partially, on the type of mutagenic treatment and/or on the stage in which cells were exposed. This fact is not completely unexpected, and, as already above mentioned, it can reflect the different experimental conditions used during UV light or chemical treatment, and also the modality by which UVB generates DSB and the two chemicals are bioactivated to DNA-damaging agents. However, the induction of nuclear foci, when expressed as excess of foci per nucleus per unit dose, seems to behaviour in a comparable fashion in both cycling and non-cycling lymphocytes and type of treatment. In fact, these values saturate with the dose, i.e. they decreased with increasing either UVB fluence or chemical concentration, as was already observed in the case of a human cell line exposed to ionising radiation (27) . It should also be underlined that we exposed in vitro circulating lymphocytes to environmentally or chemotherapeutically compatible dosages. In fact, the UVB doses or chemical concentrations applied fall into the range corresponding to a natural solar human exposure of approximately 2 h (2-8 kJ/m 2 ) (44) or to an in vivo administration of cancer therapy. This assumes further relevance in the case of simultaneous exposures to different mutagens that can synergise each other, or in the case of multiple exposures to similar genotoxins where a partial impairment of the functioning of the DDR machinery could be expected. For example, benzo[a]pyrene was able to produce reactive oxygen species in Chinese hamster ovary-K1 cells after exposure to solar-simulated light that, in turn, caused formation of γ-H2AX foci (45) . It has also been demonstrated that loss of MMR and p53 function exerts opposite and independent effects on apoptosis and chromosomal damage induced by BLM in human cancer cell lines (46) . Also in the case of UVB exposure, other types of genotoxic damage, altering one or more of the key proteins involved in the UVB-mediated cell death pathway, can, in turn, initiate skin carcinogenesis (47) . Thus, evaluating the time-course of nuclear phosphorylation of a cell population at a given moment allows us to gain information on the current status of the DDR apparatus and on the ability of that cell system to counteract transformation of further lesions into de novo chromosome mutations. Such an analysis should, therefore, be introduced in biomonitoring studies of human populations as an adjunctive biomarker that can be investigated (i) in cells from healthy subjects in vitro treated with some physical or chemical mutagens to appositely induce genome damage, and (ii) in ex vivo cells from people for whom particular exposures or pathological conditions are suspected to generate genome damage. This could also represent a feasible and useful tool in the screening and diagnosis of precancerous states or very early stages of other diseases.
